Literature DB >> 32016348

When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureus.

Richard Kuehl1,2, Laura Morata1, Sylvain Meylan2,3, Josep Mensa1, Alex Soriano1.   

Abstract

Staphylococcus aureus is a major human pathogen causing a vast array of infections with significant mortality. Its versatile physiology enables it to adapt to various environments. Specific physiological changes are thought to underlie the frequent failure of antimicrobial therapy despite susceptibility in standard microbiological assays. Bacteria capable of surviving high antibiotic concentrations despite having a genetically susceptible background are described as 'antibiotic tolerant'. In this review, we put current knowledge on environmental triggers and molecular mechanisms of increased antibiotic survival of S. aureus into its clinical context. We discuss animal and clinical evidence of its significance and outline strategies to overcome infections with antibiotic-tolerant S. aureus.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32016348     DOI: 10.1093/jac/dkz559

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Human serum triggers antibiotic tolerance in Staphylococcus aureus.

Authors:  Elizabeth V K Ledger; Stéphane Mesnage; Andrew M Edwards
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

2.  Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice.

Authors:  Wenwen Huo; Lindsay M Busch; Juan Hernandez-Bird; Efrat Hamami; Christopher W Marshall; Edward Geisinger; Vaughn S Cooper; Tim van Opijnen; Jason W Rosch; Ralph R Isberg
Journal:  Nat Microbiol       Date:  2022-05-26       Impact factor: 30.964

3.  In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe.

Authors:  Cecilia G Carvalhaes; Leonard R Duncan; Wen Wang; Helio S Sader
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

4.  Genotypic and Phenotypic Characterization of Staphylococcus aureus Isolates from the Respiratory Tract in Mechanically-Ventilated Patients.

Authors:  Alicia Lacoma; Maisem Laabei; Jose Francisco Sánchez-Herrero; Bernadette Young; Gerard Godoy-Tena; Meissiner Gomes-Fernandes; Lauro Sumoy; Oriol Plans; Fernando Arméstar; Cristina Prat
Journal:  Toxins (Basel)       Date:  2021-02-06       Impact factor: 4.546

5.  Niche-specific genome degradation and convergent evolution shaping Staphylococcus aureus adaptation during severe infections.

Authors:  Stefano G Giulieri; Romain Guérillot; Sebastian Duchene; Abderrahman Hachani; Diane Daniel; Torsten Seemann; Joshua S Davis; Steven Y C Tong; Bernadette C Young; Daniel J Wilson; Timothy P Stinear; Benjamin P Howden
Journal:  Elife       Date:  2022-06-14       Impact factor: 8.713

6.  The general stress response of Staphylococcus aureus promotes tolerance of antibiotics and survival in whole human blood.

Authors:  Nisha Ranganathan; Rebecca Johnson; Andrew M Edwards
Journal:  Microbiology (Reading)       Date:  2020-10-23       Impact factor: 2.777

Review 7.  Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review.

Authors:  Rodrigo Cuiabano Paes Leme; Paulo José Martins Bispo; Mauro José Salles
Journal:  Braz J Infect Dis       Date:  2021-02-16       Impact factor: 3.257

8.  RexAB Promotes the Survival of Staphylococcus aureus Exposed to Multiple Classes of Antibiotics.

Authors:  Rebecca S Clarke; Kam Pou Ha; Andrew M Edwards
Journal:  Antimicrob Agents Chemother       Date:  2021-07-26       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.